Full Product Name
THAP1 (THAP Domain-containing Protein 1, 4833431A01Rik, DYT6, FLJ10477, MGC33014)
Product Synonym Names
Anti -THAP1 (THAP Domain-containing Protein 1, 4833431A01Rik, DYT6, FLJ10477, MGC33014)
Product Gene Name
anti-THAP1 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence
MVQSCSAYGC KNRYDKDKPV SFHKFPLTRP SLCKEWEAAV RRKNFKPTKY SSICSEHFTP DCFKRECNNK LLKENAVPTI FLCTEPHDKK EDLLEPQEQL PPPPLPPPVS QVDAAIGLLM PPLQTPVNLS VFCDHNYTVE DTMHQRKRIH QLEQQVEKLR KKLKTAQQRC RRQERQLEKL KEVVHFQKEK DDVSERGYVI LPNDYFEIVE VPA
Chromosome Location
Chromosome: 8; NC_000008.10 (42691817..42698474, complement). Location: 8p11.21
3D Structure
ModBase 3D Structure for Q9NVV9
Specificity
Recognizes human THAP1.
Purity/Purification
Affinity Purified
Purified by Protein A affinity chromatography.
Form/Format
Supplied as a liquid in PBS, pH 7.2.
Immunogen
Full length human THAP1, aa1-213 (NP_060575.1).
Preparation and Storage
May be stored at 4 degree C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Other Notes
Small volumes of anti-THAP1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-THAP1 antibody
DNA-binding transcription regulator that regulates endothelial cell proliferation and G1/S cell-cycle progression. Specifically binds the 5'-[AT]NTNN[GT]GGCA[AGT]-3' core DNA sequence and acts by modulating expression of pRB-E2F cell-cycle target genes, including RRM1. Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. May also have pro-apoptopic activity by potentiating both serum-withdrawal and TNF-induced apoptosis.
Product Categories/Family for anti-THAP1 antibody
Antibodies; Abs to Transcription Factors
Applications Tested/Suitable for anti-THAP1 antibody
Western Blot (WB)
Application Notes for anti-THAP1 antibody
Suitable for use in Western Blot.
NCBI/Uniprot data below describe general gene information for THAP1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_945354.1
[Other Products]
NCBI GenBank Nucleotide #
NM_199003.1
[Other Products]
UniProt Primary Accession #
Q9NVV9
[Other Products]
UniProt Secondary Accession #
Q53FQ1; Q6IA99; A6NCB6; D3DSY5; H9KV49[Other Products]
UniProt Related Accession #
Q9NVV9[Other Products]
Molecular Weight
24,944 Da[Similar Products]
NCBI Official Full Name
THAP domain-containing protein 1 isoform 2
NCBI Official Synonym Full Names
THAP domain containing, apoptosis associated protein 1
NCBI Official Symbol
THAP1 [Similar Products]
NCBI Official Synonym Symbols
DYT6
[Similar Products]
NCBI Protein Information
THAP domain-containing protein 1; 4833431A01Rik; THAP domain protein 1; nuclear proapoptotic factor
UniProt Protein Name
THAP domain-containing protein 1
Protein Family
THAP domain-containing protein
UniProt Gene Name
THAP1 [Similar Products]
UniProt Entry Name
THAP1_HUMAN
NCBI Summary for THAP1
The protein encoded by this gene contains a THAP domain, a conserved DNA-binding domain. This protein colocalizes with the apoptosis response protein PAWR/PAR-4 in promyelocytic leukemia (PML) nuclear bodies, and functions as a proapoptotic factor that links PAWR to PML nuclear bodies. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
UniProt Comments for THAP1
THAP1: DNA-binding transcription regulator that regulates endothelial cell proliferation and G1/S cell-cycle progression. Specifically binds the 5'-[AT]NTNN[GT]GGCA[AGT]-3' core DNA sequence and acts by modulating expression of pRB-E2F cell-cycle target genes, including RRM1. Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. May also have pro-apoptopic activity by potentiating both serum-withdrawal and TNF-induced apoptosis. Defects in THAP1 are the cause of dystonia type 6 (DYT6). DYT6 is a primary torsion dystonia. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. Dystonia type 6 is characterized by onset in early *****hood, cranial or cervical involvement in about half of the cases, and frequent progression to involve multiple body regions. Belongs to the THAP1 family.
Protein type: Cell cycle regulation; Transcription factor; DNA-binding
Chromosomal Location of Human Ortholog: 8p11.21
Cellular Component: PML body; nucleus
Molecular Function: protein binding; zinc ion binding; sequence-specific DNA binding
Biological Process: regulation of transcription, DNA-dependent; transcription, DNA-dependent; endothelial cell proliferation; regulation of mitotic cell cycle; cell cycle
Disease: Dystonia 6, Torsion
Research Articles on THAP1
1. The genotypic spectrum of THAP1 and strengthen the association with upper body involvement, including the cranial and cervical regions that are usually spared in DYT1-primary dystonia.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.